Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time
Not Applicable
Withdrawn
- Conditions
- Dry Eye
- Registration Number
- NCT01417013
- Lead Sponsor
- Alcon Research
- Brief Summary
The primary objective of this study is assess the Tear Film break-up time (TBUT) in mild to moderate dry eye subjects.
- Detailed Description
The primary objective of this study is assess the tear film break-up time in mild to moderate dry eye subjects.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Corrected VA of 0.6 LogMar or better OU
Exclusion:
- Topical ocular medication use
- Presence of Ocular conditions (blepharitis, conjunctival infections, etc)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method TBUT 14 Days Tear Film break-up time
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie SYSTANE® ULTRA's effect on tear film stability in dry eye?
How does SYSTANE® ULTRA compare to Optive™ in improving TBUT in mild to moderate dry eye patients?
Are there specific biomarkers that correlate with improved TBUT in dry eye treatment trials?
What are the potential adverse events associated with SYSTANE® ULTRA in dry eye management?
What are the current drug classes and emerging therapies for mild to moderate dry eye treatment?